
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of TRANSGENE S.A. by TRANSGENE S.A. (OTCPK:TRGNF) through any online brokerage.
There are no as such competitors for TRANSGENE S.A. by TRANSGENE S.A..
There is no analysis for TRANSGENE S.A. by TRANSGENE S.A. to provide a consensus price target.
The stock price for TRANSGENE S.A. by TRANSGENE S.A. (OTCPK: TRGNF) is $0.8 last updated October 20, 2026 at 9:30 AM EDT.
There are no upcoming dividends for TRANSGENE S.A. by TRANSGENE S.A..
TRANSGENE S.A. by TRANSGENE S.A. does not have any upcoming earnings scheduled.
There is no upcoming split for TRANSGENE S.A. by TRANSGENE S.A..
TRANSGENE S.A. by TRANSGENE S.A. is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.
Transgene SA is a biotechnology company that designs and develops virus based immunotherapy products focused on the development of individualized therapeutic vaccines against cancers. The flagship program, TG4050, is an individualized therapeutic...